The relevance of altered Sdc-1 expression in breast cancer has been highlighted by several functional studies: previously, we could show that in triple-negative breast cancer cells, Sdc-1 knockdown significantly downregulated the expression of several cytokines and chemokines, and decreased the constitutive activation of STAT3 and NF-κB, thereby increasing the sensitivity of breast cancer cells to radiation therapy [15]. The gene discussed is NFKB1; the disease is breast cancer.